Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
P/S ratio for Marinus Pharmaceuticals (MRNS)
P/S ratio as of May 2024 (TTM): 2.57
According to Marinus Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.57027. At the end of 2023 the company had a P/S ratio of 19.1.
P/S ratio history for Marinus Pharmaceuticals from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 19.1 | 146.97% |
| 2022 | 7.75 | -72.77% |
| 2021 | 28.5 | -89.04% |
| 2020 | 260 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 2.74 | 6.57% | 🇺🇸 USA |
 Endo International
ENDPQ | 0.0001 | -100.00% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | 22.4 | 771.30% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | 0.2214 | -91.39% | 🇺🇸 USA |